Eurepa MF (Repaglinide/ Metformin) 1/500mg – 100 tablet

$75.52

Each Eurepa MF contains 1 mg Repaglinide 500 mg Metformin 100 tablets. Used to treat diabetic adults who suffer from Diabetes Mellitus type 2 diabetes.

ATC Classification: A10BD14
Active Ingrediant: Repaglinide/Metformin
Generic Name: Eurepa MF
Manufacturer: Torrent
Strength: 1/500mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 TABLET

Description

 

What is this drug used for?

It is used to lower blood sugar in patients with high blood sugar (diabetes).

 

Pronunciation

(re PAG li nide & met FOR min)

 

Medication Safety Issues

Sound-alike/look-alike issues:

PrandiMet may be confused with Avandamet, Prandin

 

Storage/Stability

Do not store above 25?C (77?F). Protect from moisture.

 

Adverse Reactions

The following information reflects the frequency of adverse effects experienced by patients who received the repaglinide/metformin fixed-dose combination product. Also see individual agents.

>10%:

Central nervous system: Headache (22%)

Endocrine & metabolic: Hypoglycemia (33%)

Gastrointestinal: Diarrhea (19%), nausea (15%)

Respiratory: Upper respiratory tract infection (11%)

Additional information

Active Ingrediant

Repaglinide/ Metformin

Generic Name

Eurepa

Alternate Names

Fulaihe, Magicnorm, Panmeglin, Repanorm M, Replitza

Strength

1/500mg

Dosage Type

Tablet

Packaging Type

Foil in Box